ABL1 and acute myeloid leukemia: In 27 CN-AML patients with high initial BAALC/ABL1 expression levels, Weber et al. [11] observed shorter EFS for individuals with sustained high BAALC/ABL1 expression levels in peripheral blood or bone marrow after two induction cycles.